25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Alvotech
Buy, Hold or Sell?

Let's analyze Alvotech together

I guess you are interested in Alvotech. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Alvotech. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Alvotech

I send you an email if I find something interesting about Alvotech.

1. Quick Overview

1.1. Quick analysis of Alvotech (30 sec.)










1.2. What can you expect buying and holding a share of Alvotech? (30 sec.)

How much money do you get?

How much money do you get?
$0.01
When do you have the money?
1 year
How often do you get paid?
9.1%

What is your share worth?

Current worth
$-2.01
Expected worth in 1 year
$-2.43
How sure are you?
22.7%

+ What do you gain per year?

Total Gains per Share
$-0.41
Return On Investment
-3.2%

For what price can you sell your share?

Current Price per Share
$12.92
Expected price per share
$10.12 - $13.22
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Alvotech (5 min.)




Live pricePrice per Share (EOD)
$12.92
Intrinsic Value Per Share
$-7.13 - $-8.09
Total Value Per Share
$-9.13 - $-10.09

2.2. Growth of Alvotech (5 min.)




Is Alvotech growing?

Current yearPrevious yearGrowGrow %
How rich?-$605.9m-$493.9m-$220.5m-30.9%

How much money is Alvotech making?

Current yearPrevious yearGrowGrow %
Making money-$154.5m-$103.9m-$50.6m-32.7%
Net Profit Margin-803.6%295.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Alvotech (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Alvotech?

Welcome investor! Alvotech's management wants to use your money to grow the business. In return you get a share of Alvotech.

First you should know what it really means to hold a share of Alvotech. And how you can make/lose money.

Speculation

The Price per Share of Alvotech is $12.92. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Alvotech.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Alvotech, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-2.01. Based on the TTM, the Book Value Change Per Share is $-0.11 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.15 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Alvotech.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.221.7%-0.51-4.0%0.040.3%-0.19-1.4%-0.19-1.4%
Usd Book Value Change Per Share0.181.4%-0.11-0.8%-0.15-1.2%-0.10-0.8%-0.09-0.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.181.4%-0.10-0.8%-0.15-1.1%-0.10-0.8%-0.09-0.7%
Usd Price Per Share12.16-11.25-9.35-7.52-6.84-
Price to Earnings Ratio14.07-0.77--13.36--5.05--4.59-
Price-to-Total Gains Ratio69.40-13.71-16.81--37.83--37.83-
Price to Book Ratio-6.06--4.89--5.88--18.64--16.94-
Price-to-Total Gains Ratio69.40-13.71-16.81--37.83--37.83-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share12.92
Number of shares77
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.11-0.10
Usd Total Gains Per Share-0.10-0.10
Gains per Quarter (77 shares)-7.86-7.62
Gains per Year (77 shares)-31.43-30.48
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
11-32-410-31-40
22-65-721-62-70
33-97-1031-93-100
44-130-1342-124-130
55-162-1652-155-160
66-195-1963-185-190
77-227-2273-216-220
88-260-2583-247-250
910-292-2894-278-280
1011-325-3204-309-310

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%4.08.00.033.3%4.016.00.020.0%4.018.00.018.2%4.018.00.018.2%
Book Value Change Per Share2.02.00.050.0%4.07.01.033.3%5.08.07.025.0%5.08.09.022.7%5.08.09.022.7%
Dividend per Share1.00.03.025.0%2.00.010.016.7%2.00.018.010.0%2.00.020.09.1%2.00.020.09.1%
Total Gains per Share2.02.00.050.0%4.07.01.033.3%5.08.07.025.0%5.08.09.022.7%5.08.09.022.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Alvotech compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.175-0.105+160%-0.151+186%-0.100+157%-0.091+152%
Book Value Per Share---2.007-2.366+18%-1.636-18%-1.056-47%-0.960-52%
Current Ratio--0.2370.848-72%1.193-80%1.072-78%0.975-76%
Debt To Asset Ratio--1.5671.715-9%1.586-1%1.624-4%1.477+6%
Debt To Equity Ratio----0%-0%-0%-0%
Dividend Per Share---0.003-100%0.003-100%0.001-100%0.001-100%
Eps--0.216-0.512+337%0.041+427%-0.187+187%-0.186+186%
Free Cash Flow Per Share---0.191-0.284+49%-0.287+50%-0.216+13%-0.204+7%
Free Cash Flow To Equity Per Share---0.178-0.041-77%-0.059-67%-0.032-82%-0.036-80%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---8.086--------
Intrinsic Value_10Y_min---7.128--------
Intrinsic Value_1Y_max---1.096--------
Intrinsic Value_1Y_min---1.077--------
Intrinsic Value_3Y_max---3.075--------
Intrinsic Value_3Y_min---2.940--------
Intrinsic Value_5Y_max---4.792--------
Intrinsic Value_5Y_min---4.466--------
Market Cap3901116480.000+6%3671639040.0003395360280.000+8%2823176400.000+30%2271826656.000+62%2065296960.000+78%
Net Profit Margin--1.220-8.036+759%2.956-59%-18.331+1603%-17.263+1515%
Operating Margin---0.999-2.941+195%-7.120+613%-18.383+1741%-16.886+1591%
Operating Ratio--1.9994.322-54%9.463-79%16.451-88%14.689-86%
Pb Ratio-6.438-6%-6.060-4.886-19%-5.884-3%-18.635+208%-16.941+180%
Pe Ratio14.953+6%14.0730.767+1736%-13.362+195%-5.046+136%-4.587+133%
Price Per Share12.920+6%12.16011.245+8%9.350+30%7.524+62%6.840+78%
Price To Free Cash Flow Ratio-16.907-6%-15.912-10.999-31%-8.771-45%-8.760-45%-7.964-50%
Price To Total Gains Ratio73.741+6%69.40313.706+406%16.806+313%-37.832+155%-37.832+155%
Quick Ratio--0.1380.416-67%0.662-79%0.691-80%0.628-78%
Return On Assets--0.061-0.158+359%-0.125+305%-0.177+390%-0.161+363%
Return On Equity----0%-0%-0%-0%
Total Gains Per Share--0.175-0.102+158%-0.148+184%-0.099+156%-0.090+151%
Usd Book Value---605922000.000-714523000.000+18%-493988750.000-18%-318796800.000-47%-289815272.727-52%
Usd Book Value Change Per Share--0.175-0.105+160%-0.151+186%-0.100+157%-0.091+152%
Usd Book Value Per Share---2.007-2.366+18%-1.636-18%-1.056-47%-0.960-52%
Usd Dividend Per Share---0.003-100%0.003-100%0.001-100%0.001-100%
Usd Eps--0.216-0.512+337%0.041+427%-0.187+187%-0.186+186%
Usd Free Cash Flow---57686000.000-85749750.000+49%-86656500.000+50%-65191275.000+13%-61460250.000+7%
Usd Free Cash Flow Per Share---0.191-0.284+49%-0.287+50%-0.216+13%-0.204+7%
Usd Free Cash Flow To Equity Per Share---0.178-0.041-77%-0.059-67%-0.032-82%-0.036-80%
Usd Market Cap3901116480.000+6%3671639040.0003395360280.000+8%2823176400.000+30%2271826656.000+62%2065296960.000+78%
Usd Price Per Share12.920+6%12.16011.245+8%9.350+30%7.524+62%6.840+78%
Usd Profit--65225000.000-154595250.000+337%-103990750.000+259%-68605300.000+205%-67138363.636+203%
Usd Revenue--53482000.00034272750.000+56%15791500.000+239%18831800.000+184%17845227.273+200%
Usd Total Gains Per Share--0.175-0.102+158%-0.148+184%-0.099+156%-0.090+151%
 EOD+6 -2MRQTTM+25 -8YOY+21 -125Y+21 -1210Y+20 -13

3.3 Fundamental Score

Let's check the fundamental score of Alvotech based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1514.953
Price to Book Ratio (EOD)Between0-1-6.438
Net Profit Margin (MRQ)Greater than01.220
Operating Margin (MRQ)Greater than0-0.999
Quick Ratio (MRQ)Greater than10.138
Current Ratio (MRQ)Greater than10.237
Debt to Asset Ratio (MRQ)Less than11.567
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.061
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Alvotech based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5063.895
Ma 20Greater thanMa 5012.734
Ma 50Greater thanMa 10011.955
Ma 100Greater thanMa 20012.033
OpenGreater thanClose12.950
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Alvotech

Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, Crohn's disease, ulcerative colitis, plaque psoriasis, and other indications; AVT04, a biosimilar to Stelara to treat various inflammatory conditions comprising psoriatic arthritis, Crohn's disease, ulcerative colitis, plaque psoriasis, and other indications; AVT06, a biosimilar to Eylea to treat various conditions, such as age-related macular degeneration, macular edema, and diabetic retinopathy; and AVT03, a biosimilar to Xgeva and Prolia, which is in the pre-clinical phase to treat prevent bone fracture, spinal cord compression, and the need for radiation or bone surgery in patients with certain types of cancer, as well as prevent bone loss and increase bone mass. In addition, it offers AVT05, a biosimilar to Simponi and Simponi Aria, which is in early phase development to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and other indications; AVT16, a biosimilar to an Entyvio product; AVT23, a biosimilar to Xolair, which is in late-stage development to treat nasal polyps; and AVT33, a biosimilar to an Keytruda product. Alvotech was founded in 2013 and is based in Luxembourg, Luxembourg.

Fundamental data was last updated by Penke on 2024-10-23 11:51:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Alvotech earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Alvotech to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 122.0% means that $1.22 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Alvotech:

  • The MRQ is 122.0%. The company is making a huge profit. +2
  • The TTM is -803.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ122.0%TTM-803.6%+925.5%
TTM-803.6%YOY295.6%-1,099.1%
TTM-803.6%5Y-1,833.1%+1,029.6%
5Y-1,833.1%10Y-1,726.3%-106.9%
4.3.1.2. Return on Assets

Shows how efficient Alvotech is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Alvotech to the Drug Manufacturers - Specialty & Generic industry mean.
  • 6.1% Return on Assets means that Alvotech generated $0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Alvotech:

  • The MRQ is 6.1%. Using its assets, the company is efficient in making profit. +1
  • The TTM is -15.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ6.1%TTM-15.8%+21.9%
TTM-15.8%YOY-12.5%-3.3%
TTM-15.8%5Y-17.7%+1.9%
5Y-17.7%10Y-16.1%-1.6%
4.3.1.3. Return on Equity

Shows how efficient Alvotech is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Alvotech to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.0% Return on Equity means Alvotech generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Alvotech:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Alvotech.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Alvotech is operating .

  • Measures how much profit Alvotech makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Alvotech to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -99.9% means the company generated $-1.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Alvotech:

  • The MRQ is -99.9%. The company is operating very inefficient. -2
  • The TTM is -294.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-99.9%TTM-294.1%+194.3%
TTM-294.1%YOY-712.0%+417.9%
TTM-294.1%5Y-1,838.3%+1,544.1%
5Y-1,838.3%10Y-1,688.6%-149.6%
4.3.2.2. Operating Ratio

Measures how efficient Alvotech is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 2.00 means that the operating costs are $2.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Alvotech:

  • The MRQ is 1.999. The company is inefficient in keeping operating costs low. -1
  • The TTM is 4.322. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.999TTM4.322-2.323
TTM4.322YOY9.463-5.141
TTM4.3225Y16.451-12.129
5Y16.45110Y14.689+1.761
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Alvotech.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Alvotech is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.24 means the company has $0.24 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Alvotech:

  • The MRQ is 0.237. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.848. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.237TTM0.848-0.611
TTM0.848YOY1.193-0.345
TTM0.8485Y1.072-0.225
5Y1.07210Y0.975+0.097
4.4.3.2. Quick Ratio

Measures if Alvotech is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Alvotech to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.14 means the company can pay off $0.14 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Alvotech:

  • The MRQ is 0.138. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.416. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.138TTM0.416-0.277
TTM0.416YOY0.662-0.246
TTM0.4165Y0.691-0.276
5Y0.69110Y0.628+0.063
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Alvotech.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Alvotech assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Alvotech to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 1.57 means that Alvotech assets are financed with 156.7% credit (debt) and the remaining percentage (100% - 156.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Alvotech:

  • The MRQ is 1.567. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.715. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.567TTM1.715-0.148
TTM1.715YOY1.586+0.129
TTM1.7155Y1.624+0.090
5Y1.62410Y1.477+0.148
4.5.4.2. Debt to Equity Ratio

Measures if Alvotech is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Alvotech to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Alvotech:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Alvotech generates.

  • Above 15 is considered overpriced but always compare Alvotech to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 14.07 means the investor is paying $14.07 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Alvotech:

  • The EOD is 14.953. Based on the earnings, the company is underpriced. +1
  • The MRQ is 14.073. Based on the earnings, the company is underpriced. +1
  • The TTM is 0.767. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD14.953MRQ14.073+0.880
MRQ14.073TTM0.767+13.306
TTM0.767YOY-13.362+14.129
TTM0.7675Y-5.046+5.813
5Y-5.04610Y-4.587-0.459
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Alvotech:

  • The EOD is -16.907. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -15.912. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -10.999. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-16.907MRQ-15.912-0.995
MRQ-15.912TTM-10.999-4.913
TTM-10.999YOY-8.771-2.228
TTM-10.9995Y-8.760-2.239
5Y-8.76010Y-7.964-0.796
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Alvotech is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Alvotech:

  • The EOD is -6.438. Based on the equity, the company is expensive. -2
  • The MRQ is -6.060. Based on the equity, the company is expensive. -2
  • The TTM is -4.886. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.438MRQ-6.060-0.379
MRQ-6.060TTM-4.886-1.174
TTM-4.886YOY-5.884+0.998
TTM-4.8865Y-18.635+13.749
5Y-18.63510Y-16.941-1.694
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Alvotech.

4.8.2. Funds holding Alvotech

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-08-31Vanguard Total Intl Stock Index Inv0.37810.0029113984800
2024-08-31Vanguard Emerging Mkts Stock Idx Inv0.36090.0116108791200
2024-09-30Redwheel Next Gen Em Mkts Eq I USD Acc0.21850.906365885500
2024-08-31Vanguard Instl Ttl Intl Stk Mkt Idx TrII0.1890.003569671128962.3162
2024-09-30SEI Emerging Markets Equity A (SIIT)0.08530.32425715400
2024-09-30Vanguard FTSE All-Wld ex-US ETF0.05470.003316491013890.8494
2024-08-31Fidelity Nasdaq Composite Index0.0520.010615681600
2024-09-28Schwab Emerging Markets Equity ETF™0.03210.01159673500
2024-08-31T. Rowe Price Frontier Mkts Eq I USD0.0270.97868136000
2024-08-31Vanguard Instl Ttl Intl Stck Mkt Idx Tr0.0270.0038130400
2024-09-30SSGA Emerging Markets Equity Index0.02370.01377154600
2024-09-30Fidelity Nasdaq Composite ETF0.01740.009152441-54-0.1029
2024-08-31UWS Blackrock Emerging Markets Eq Trkr B0.0170.01115114200
2024-08-31Vanguard Total World Stock ETF0.01470.0014433500
2024-09-30undrly Fid DC L&G World Em Mkts HN Life0.01410.01284251600
2024-08-31Vanguard FTSE All-World UCITS ETF0.01290.00163889200
2024-09-30Stt Strt AUT Em MktScrn(ex Cont&CW)IdxEq0.01240.01213732000
2024-06-30Northern Small Cap Core I0.01170.110935205352050
2024-07-31Eurizon Equity EmMkts New Frntrs Z Acc0.01130.73134086333910.8596
2024-08-31Vanguard FTSE Emerg Markets ETF $Dis0.01020.0122308002240.7326
Total 1.573.17034732848+52999+1.1%
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-06-302023-09-302023-12-312024-03-312024-06-30
Gross Profit  -24,4235,684-18,73915,710-3,029-4,498-7,52715,7998,272
Tax Provision  -20,4743,252-17,222-15,020-32,24225,804-6,43818,00811,570
Income Tax Expense  -20,4743,252-17,222-15,020-32,24225,804-6,43818,00811,570



5.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets1,068,478
Total Liabilities1,674,400
Total Stockholder Equity-605,922
 As reported
Total Liabilities 1,674,400
Total Stockholder Equity+ -605,922
Total Assets = 1,068,478

Assets

Total Assets1,068,478
Total Current Assets285,193
Long-term Assets783,285
Total Current Assets
Cash And Cash Equivalents 10,944
Net Receivables 155,513
Inventory 96,574
Other Current Assets 22,162
Total Current Assets  (as reported)285,193
Total Current Assets  (calculated)285,193
+/-0
Long-term Assets
Property Plant Equipment 377,645
Goodwill 11,692
Intangible Assets 19,901
Long-term Assets Other 8,952
Long-term Assets  (as reported)783,285
Long-term Assets  (calculated)418,190
+/- 365,095

Liabilities & Shareholders' Equity

Total Current Liabilities1,202,466
Long-term Liabilities471,934
Total Stockholder Equity-605,922
Total Current Liabilities
Short-term Debt 1,009,680
Short Long Term Debt 999,036
Accounts payable 58,566
Other Current Liabilities 129,736
Total Current Liabilities  (as reported)1,202,466
Total Current Liabilities  (calculated)2,197,018
+/- 994,552
Long-term Liabilities
Long term Debt 56,877
Capital Lease Obligations 132,517
Long-term Liabilities  (as reported)471,934
Long-term Liabilities  (calculated)189,394
+/- 282,540
Total Stockholder Equity
Common Stock2,602
Retained Earnings -2,359,349
Accumulated Other Comprehensive Income 34,220
Other Stockholders Equity 1,716,605
Total Stockholder Equity (as reported)-605,922
Total Stockholder Equity (calculated)-605,922
+/-0
Other
Capital Stock2,602
Cash and Short Term Investments 10,944
Common Stock Shares Outstanding 279,408
Current Deferred Revenue4,484
Liabilities and Stockholders Equity 1,068,478
Net Debt 1,177,486
Net Invested Capital 449,991
Net Working Capital -917,273
Property Plant and Equipment Gross 377,645
Short Long Term Debt Total 1,188,430



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
0
0
0
0
118,606
118,606
118,606
118,606
149,494
149,494
149,494
597,977
207,111
774,497
683,126
828,443
895,465
910,662
958,819
950,090
1,060,637
1,068,478
1,068,4781,060,637950,090958,819910,662895,465828,443683,126774,497207,111597,977149,494149,494149,494118,606118,606118,606118,6060000
   > Total Current Assets 
0
0
0
0
21,540
21,540
21,540
21,540
29,954
29,954
29,954
119,816
57,684
238,660
153,673
230,736
269,141
211,912
228,391
194,842
292,296
285,193
285,193292,296194,842228,391211,912269,141230,736153,673238,66057,684119,81629,95429,95429,95421,54021,54021,54021,5400000
       Cash And Cash Equivalents 
0
0
0
0
7,922
7,922
7,922
7,922
4,389
4,389
4,389
17,556
16,607
128,438
12,844
66,427
115,844
60,466
68,315
11,157
64,811
10,944
10,94464,81111,15768,31560,466115,84466,42712,844128,43816,60717,5564,3894,3894,3897,9227,9227,9227,9220000
       Net Receivables 
0
0
0
0
9,726
9,726
9,726
9,726
13,471
13,471
13,471
53,882
17,847
38,191
51,160
71,387
46,262
49,450
42,050
87,217
72,349
155,513
155,51372,34987,21742,05049,45046,26271,38751,16038,19117,84753,88213,47113,47113,4719,7269,7269,7269,7260000
       Other Current Assets 
0
0
0
0
1,481
1,481
1,481
1,481
2,330
2,330
2,330
9,320
5,363
17,367
22,210
21,452
31,799
22,630
36,031
22,035
62,900
22,162
22,16262,90022,03536,03122,63031,79921,45222,21017,3675,3639,3202,3302,3302,3301,4811,4811,4811,4810000
   > Long-term Assets 
0
0
0
0
97,065
97,065
97,065
97,065
119,540
119,540
119,540
478,161
149,427
535,837
529,453
597,707
626,324
698,750
730,428
755,248
768,341
783,285
783,285768,341755,248730,428698,750626,324597,707529,453535,837149,427478,161119,540119,540119,54097,06597,06597,06597,0650000
       Property Plant Equipment 
0
0
0
0
44,241
44,241
44,241
44,241
51,333
51,333
51,333
205,331
67,024
218,480
229,323
268,095
272,321
333,391
343,462
356,581
362,834
377,645
377,645362,834356,581343,462333,391272,321268,095229,323218,48067,024205,33151,33351,33351,33344,24144,24144,24144,2410000
       Goodwill 
0
0
0
0
3,357
3,357
3,357
3,357
3,092
3,092
3,092
12,367
2,911
11,436
10,656
11,643
11,911
11,886
11,555
12,058
11,779
11,692
11,69211,77912,05811,55511,88611,91111,64310,65611,4362,91112,3673,0923,0923,0923,3573,3573,3573,3570000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
55,307
0
51,334
47,683
48,568
47,586
43,613
42,035
18,494
18,494
0
018,49418,49442,03543,61347,58648,56847,68351,334055,30700000000000
       Intangible Assets 
0
0
0
0
1,584
1,584
1,584
1,584
5,377
5,377
5,377
21,509
6,413
22,857
22,915
25,652
14,527
14,007
20,283
19,076
19,370
19,901
19,90119,37019,07620,28314,00714,52725,65222,91522,8576,41321,5095,3775,3775,3771,5841,5841,5841,5840000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
231,730
231,730
218,876
243,749
0
295,853
0
0
0
0
0000295,8530243,749218,876231,730231,730000000000000
> Total Liabilities 
0
0
0
0
335,416
335,416
335,416
335,416
183,397
183,397
183,397
733,589
348,215
1,070,718
960,358
1,392,859
1,551,232
1,389,202
1,619,671
1,882,583
1,719,462
1,674,400
1,674,4001,719,4621,882,5831,619,6711,389,2021,551,2321,392,859960,3581,070,718348,215733,589183,397183,397183,397335,416335,416335,416335,4160000
   > Total Current Liabilities 
0
0
0
0
12,745
12,745
12,745
12,745
27,959
27,959
27,959
111,836
41,824
277,786
202,481
167,294
160,334
221,693
186,754
260,950
246,785
1,202,466
1,202,466246,785260,950186,754221,693160,334167,294202,481277,78641,824111,83627,95927,95927,95912,74512,74512,74512,7450000
       Short-term Debt 
0
0
0
0
626
626
626
626
693
693
693
10,066
4,979
128,118
83,020
25,079
28,270
30,446
22,173
47,708
48,711
1,009,680
1,009,68048,71147,70822,17330,44628,27025,07983,020128,1184,97910,0666936936936266266266260000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
2,771
0
120,836
74,986
19,916
23,048
22,463
13,594
38,025
37,550
999,036
999,03637,55038,02513,59422,46323,04819,91674,986120,83602,77100000000000
       Accounts payable 
0
0
0
0
2,990
2,990
2,990
2,990
7,147
7,147
7,147
28,587
12,297
44,726
36,441
49,188
29,766
43,931
52,662
80,563
50,175
58,566
58,56650,17580,56352,66243,93129,76649,18836,44144,72612,29728,5877,1477,1477,1472,9902,9902,9902,9900000
       Other Current Liabilities 
0
0
0
0
5,581
5,581
5,581
5,581
12,697
12,697
12,697
43,491
15,319
72,614
59,133
56,112
77,451
88,338
58,500
73,496
101,641
129,736
129,736101,64173,49658,50088,33877,45156,11259,13372,61415,31943,49112,69712,69712,6975,5815,5815,5815,5810000
   > Long-term Liabilities 
0
0
0
0
322,672
322,672
322,672
322,672
155,438
155,438
155,438
621,753
306,391
792,932
757,877
1,225,565
1,390,898
1,167,509
1,432,917
1,621,633
1,472,677
471,934
471,9341,472,6771,621,6331,432,9171,167,5091,390,8981,225,565757,877792,932306,391621,753155,438155,438155,438322,672322,672322,672322,6720000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
239,441
239,441
204,144
445,542
0
293,918
0
0
0
0
0000293,9180445,542204,144239,441239,441000000000000
> Total Stockholder Equity
0
0
0
0
-216,811
-216,811
-216,811
-216,811
-33,903
-33,903
-33,903
-135,612
-141,104
-296,221
-277,232
-564,416
-655,767
-478,540
-660,852
-932,493
-658,825
-605,922
-605,922-658,825-932,493-660,852-478,540-655,767-564,416-277,232-296,221-141,104-135,612-33,903-33,903-33,903-216,811-216,811-216,811-216,8110000
   Common Stock
0
0
0
0
18
18
18
18
34
34
34
135
532
2,076
2,126
2,126
2,281
2,271
2,271
2,279
2,604
2,602
2,6022,6042,2792,2712,2712,2812,1262,1262,076532135343434181818180000
   Retained Earnings Total Equity0000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
-8,494
-8,494
-8,494
-8,494
-10,982
-10,982
-10,982
4,669
-12,778
426
-4,183
29,140
36,972
35,343
41,321
41,383
36,535
34,220
34,22036,53541,38341,32135,34336,97229,140-4,183426-12,7784,669-10,982-10,982-10,982-8,494-8,494-8,494-8,4940000
   Capital Surplus 0000000000000000000000
   Treasury Stock0000000000000000000000
   Other Stockholders Equity 
0
0
0
0
51,422
51,422
51,422
51,422
262,178
262,178
262,178
1,000,118
284,671
1,026,282
1,058,432
1,058,432
1,235,274
1,224,814
1,224,844
1,229,690
1,726,610
1,716,605
1,716,6051,726,6101,229,6901,224,8441,224,8141,235,2741,058,4321,058,4321,026,282284,6711,000,118262,178262,178262,17851,42251,42251,42251,4220000



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue91,434
Cost of Revenue-160,856
Gross Profit-69,422-69,422
 
Operating Income (+$)
Gross Profit-69,422
Operating Expense-285,438
Operating Income-354,860-354,860
 
Operating Expense (+$)
Research Development210,827
Selling General Administrative76,559
Selling And Marketing Expenses0
Operating Expense285,438287,386
 
Net Interest Income (+$)
Interest Income4,823
Interest Expense-133,167
Other Finance Cost-1,657
Net Interest Income-130,001
 
Pretax Income (+$)
Operating Income-354,860
Net Interest Income-130,001
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-651,049-188,672
EBIT - interestExpense = -492,014
-651,049
-418,564
Interest Expense133,167
Earnings Before Interest and Taxes (EBIT)-358,847-517,882
Earnings Before Interest and Taxes (EBITDA)-334,637
 
After tax Income (+$)
Income Before Tax-651,049
Tax Provision--99,318
Net Income From Continuing Ops-551,731-551,731
Net Income-551,731
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses446,294
Total Other Income/Expenses Net-166,188130,001
 

Technical Analysis of Alvotech
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Alvotech. The general trend of Alvotech is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Alvotech's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Alvotech.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 13.19 < 13.20 < 13.22.

The bearish price targets are: 10.64 > 10.18 > 10.12.

Tweet this
Alvotech Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Alvotech. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Alvotech Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Alvotech. The current macd is 0.28270595.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Alvotech price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Alvotech. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Alvotech price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Alvotech Daily Moving Average Convergence/Divergence (MACD) ChartAlvotech Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Alvotech. The current adx is 30.81.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Alvotech shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Alvotech Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Alvotech. The current sar is 9.90038843.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Alvotech Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Alvotech. The current rsi is 63.90. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
Alvotech Daily Relative Strength Index (RSI) ChartAlvotech Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Alvotech. The current phase is Overbought in neutral market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Alvotech price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Alvotech Daily Stochastic Oscillator ChartAlvotech Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Alvotech. The current cci is 70.24.

Alvotech Daily Commodity Channel Index (CCI) ChartAlvotech Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Alvotech. The current cmo is 28.12.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Alvotech Daily Chande Momentum Oscillator (CMO) ChartAlvotech Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Alvotech. The current willr is -7.22891566.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Alvotech Daily Williams %R ChartAlvotech Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Alvotech.

Alvotech Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Alvotech. The current atr is 0.41541283.

Alvotech Daily Average True Range (ATR) ChartAlvotech Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Alvotech. The current obv is 18,937,771.

Alvotech Daily On-Balance Volume (OBV) ChartAlvotech Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Alvotech. The current mfi is 65.47.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Alvotech Daily Money Flow Index (MFI) ChartAlvotech Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Alvotech.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-06-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-24BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-06-25ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-26ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-01RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-07-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-10RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-07-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-26RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-07-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-08-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-08-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-08-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-10MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-09-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-01STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-04STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-07STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-08BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-10STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Alvotech Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Alvotech based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5063.895
Ma 20Greater thanMa 5012.734
Ma 50Greater thanMa 10011.955
Ma 100Greater thanMa 20012.033
OpenGreater thanClose12.950
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Alvotech with someone you think should read this too:
  • Are you bullish or bearish on Alvotech? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Alvotech? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Alvotech

I send you an email if I find something interesting about Alvotech.


Comments

How you think about this?

Leave a comment

Stay informed about Alvotech.

Receive notifications about Alvotech in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.